EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Complete Pathway Refactoring and Combinatorial Biosynthesis of Anthracyclines for Modulation of Histone Eviction and DNA Damage Bioactivities

Rongbin Wang iD, Heli Tirkkonen, Sabina Y van der Zanden, Larissa Ponomareva, Isaline Fagon, Leslie Fève, Kendall Paige, Courtney L Brown, Nora Schwartz, Jacob Hecht, Jennifer Nguyen, Jon S Thorson iD und 4 weitere

Angewandte Chemie International Edition · 02.11.2026 · 65 (45)

DOI: 10.1002/anie.1050964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 23.09.2026. Verfasst von Rongbin Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Technologies, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Anthracyclines, DNA Damage, Histones, Antineoplastic Agents. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines including doxorubicin are cornerstone chemotherapeutic agents with high cytotoxic potency, but their use in cancer treatment is limited by irreversible dose‐dependent cardiotoxicity. Recent investigations indicate that cardiotoxicity‐free anthracyclines may be achieved through uncoupling DNA damage from chromatin damage. However, semi‐synthetic derivatization is complicated by anthracycline structural complexity. Here, we report a modular synthetic biology platform for the complete refactoring and combinatorial biosynthesis of anthracyclines in Streptomyces coelicolor M1152Δ matAB . Using standardized synthetic DNA parts, we refactored three full biosynthetic pathways of nogalamycin (38 genes), doxorubicin (31 genes), and aclacinomycin (31 genes). The pathways were organized into four functional modules (aglycone biosynthesis, TDP‐carbohydrate formation, glycosylation, and tailoring reactions) to facilitate efficient reconstruction. The modular design facilitated streamlined combinatorial biosynthesis yielding 16 derivatives, including 13 novel analogs. Bioactivity profiling across human cancer cell lines identified six potent congeners. Their cytotoxicity correlated with in vitro DNA binding affinities. Two hit molecules harbored desired bioactivity profiles promoting histone eviction at a faster rate than doxorubicin, without causing DNA double strand breaks. Our approach highlights the power of synthetic biology in rational natural product engineering and provides a scalable strategy for exploring new and improved anthracycline anti‐cancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesDNA DamageHistonesAntineoplastic AgentsHumansStreptomyces coelicolorCell Line, Tumor

Stichwörter der Autor:innen

BiobricksStreptomyces coelicoloranthracyclinesnatural product biosynthesissynthetic biology

Substanzen

AnthracyclinesHistonesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Life Technologies, University of Turku, Turku, Finland.
  • Department of Cell and Chemical Biology (CCB) and Oncode Institute, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
  • Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
  • Chemistry and Chemical Engineering Department, SIGMA Clermont, Aubière, France.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, Michigan, USA.

ORCID-Profile: Rongbin Wang, Jon S Thorson, Jacques Neefjes, S Eric Nybo, Khaled A Shaaban, Mikko Metsä-Ketelä

Förderung

  • NCATS NIH HHS
  • NIGMS NIH HHS
  • Research Council of Finland
  • National Science Foundation
  • NIH HHS
  • NCI NIH HHS
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Novo Nordisk Foundation

Zitieren

APA

Wang, R., Tirkkonen, H., van der Zanden, S. Y., Ponomareva, L., Fagon, I., Fève, L., Paige, K., Brown, C. L., Schwartz, N., Hecht, J., Nguyen, J., Thorson, J. S., Neefjes, J., Nybo, S. E., Shaaban, K. A., & Metsä-Ketelä, M. (2026). Complete Pathway Refactoring and Combinatorial Biosynthesis of Anthracyclines for Modulation of Histone Eviction and DNA Damage Bioactivities. Angewandte Chemie International Edition, 65(45). https://doi.org/10.1002/anie.1050964

Vancouver

Wang R, Tirkkonen H, van der Zanden SY, Ponomareva L, Fagon I, Fève L, et al. Complete Pathway Refactoring and Combinatorial Biosynthesis of Anthracyclines for Modulation of Histone Eviction and DNA Damage Bioactivities. Angewandte Chemie International Edition. 2026;65(45). doi:10.1002/anie.1050964

BibTeX
@article{Wang2026,
  author = {Wang, Rongbin and Tirkkonen, Heli and van der Zanden, Sabina Y and Ponomareva, Larissa and Fagon, Isaline and Fève, Leslie and Paige, Kendall and Brown, Courtney L and Schwartz, Nora and Hecht, Jacob and Nguyen, Jennifer and Thorson, Jon S and Neefjes, Jacques and Nybo, S Eric and Shaaban, Khaled A and Metsä-Ketelä, Mikko},
  title = {Complete Pathway Refactoring and Combinatorial Biosynthesis of Anthracyclines for Modulation of Histone Eviction and DNA Damage Bioactivities},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {45},
  doi = {10.1002/anie.1050964}
}
Kostenlos starten →